Polymorphisms in the Tumor Necrosis Factor Receptor Genes Affect the Expression Levels of Membrane-Bound Type I and Type II Receptors

Figure 2

(a) Number of membrane-bound TNFRI present on CD14⁺ monocytes in individuals presenting with different SNP TNFRI −1207G/C (rs4149569) genotypes. Kruskal-Wallis 𝐻 test, 𝑃=0.025, Mann-Whitney 𝑈 test: CC versus GC, 𝑃=0.012. (b) Percentage of CD14⁺ cells expressing TNFRI in individuals presenting with different SNP TNFRI −1207G/C (rs4149569) genotypes.

(a)

(b)